A fluorescent probe for detecting outer membrane vesicles and its application

By developing a fluorescent probe compound with low fluorescence background, the fluorescence is significantly enhanced after binding to OMV, the problem of strong fluorescence background in OMV research was solved, the sensitivity and quantitative ability of detection were improved, and the rapid identification of OMV generation and induction conditions was achieved. high throughput screening.

CN115466210BActive Publication Date: 2024-11-12HARBIN INST OF TECH SHENZHEN GRADUATE SCHOOL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202211154664.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-09-21
Publication Date
2024-11-12
Estimated Expiration
2042-09-21

AI Technical Summary

Technical Problem

The prior art has a strong fluorescence background in OMV research, which is difficult to conduct quantitative analysis and sensitive detection, and the experimental process is complex, which affects the difficulty of OMV research.

Method used

Develop a fluorescent probe compound with a low fluorescence background, which is enhanced after binding to OMV, for sensitive detection of OMV generation and does not emit fluorescence or emit faint fluorescence in buffer or MOPS culture until fluorescence is fluorescence when bound to OMV Significantly enhanced.

Benefits of technology

OMV detection in low context is realized, the sensitivity and quantitative ability of analysis are improved, the OMV generation and induction conditions can be quickly identified, and the high-throughput screening ability is high-throughput screening.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115466210B_ABST
    Figure CN115466210B_ABST
Patent Text Reader

Abstract

The present invention belongs to the field of detection technology, and aims to develop a fluorescent probe that can be used for OMV research. The fluorescent probe of the present invention adopts a compound having a chromophore of the following formula, and is applied to OMV detection. This type of material does not emit fluorescence or emits weak fluorescence in a buffer solution or in a MOPS culture solution. In the presence of Gram-negative bacteria, the fluorescence emitted is very weak or does not emit fluorescence. When it is bound to OMV, the fluorescence is enhanced. It is conducive to quickly identifying the production of OMV and determining the optimal conditions for inducing the production of OMV. It is of great significance for studying OMV.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of detection technology and aims to develop a fluorescent probe that can be used for OMV research. The fluorescent probe of the invention adopts a compound with a chromophore of the following formula and is applied to OMV detection. Background Art

[0002] Outer membrane vesicles (OMVs) are spherical protrusions produced by Gram-negative bacteria. OMVs are loaded with biomolecules including lipopolysaccharide, flagellin, peptidoglycan, enzymes, DNA, RNA, etc. These biomolecules enable OMVs to participate in many important biological processes, including bacterial pathogenicity, information transmission, quorum sensing, horizontal gene transmission, and response to stressful environments. In addition, OMVs also play an important role in regulating host immunity. Therefore, immunity can be induced by regulating OMVs, and then used as vaccine adjuvants. OMVs are also of great significance in the development of cancer vaccines and cancer immunotherapy.

[0003] The size of OMVs is between 20 and 250 nm, which makes it very difficult to observe OMVs in experiments.

[0004] Currently, proteomics (1) and particle tracking technology (2) are commonly used in the study of OMVs. However, these two techniques require lengthy differential centrifugation or ultrafiltration, making the study of OMVs very difficult (3-5).

[0005] Fluorescence technology has good sensitivity, but most fluorescent substances currently have strong fluorescence in solution, which produces a strong background in the process of studying OMVs. This strong background makes the quantitative analysis of OMVs very difficult and also reduces the sensitivity of the analysis.

[0006] References:

[0007] 1. W. Elhenawy, MODebelyy, MFF Fieldman, mBio 2014, 5, e00909-00914.

[0008] 2.MJHGerritzen, DEMartens, RHWijffels, M.Stork, J.Extracell.Vesicles 2017, 6, 1333883.

[0009] 3. R. Dehinwal, D. Cooley, AV Rakov, AS Alμgupalli, J. Harmon, O. Cunrath, P. Vallabhajosyula, D. Bμmann, DM Chifferli, mBio 2021, 12, e0086921;

[0010] 4. AJ Manning, MJ Kuehn, BMC Microbiol. 2011, 11, 258;

[0011] 5. A. Bauwens, L. Kunsmann, H. Karch, A. Mellmann, M. Bielaszewska, Antimcrob. Agents Chemother. 2017, 61, e00937-00917. Summary of the invention

[0012] In view of the problems existing in the prior art, the purpose of the present invention is to develop a fluorescent probe that can be used for OMV research. The fluorescent probe has a low fluorescence background, and its fluorescence is enhanced after binding to OMV, which can sensitively detect the generation of OMV and screen factors that can induce the generation of OMV in high-throughput.

[0013] A fluorescent probe for detecting outer membrane vesicles, using a compound having a chromophore of the following formula, and applying it to outer membrane vesicle (OMV) detection,

[0014]

[0015] Wherein A1, A2, A3, A4 are independently selected from And at least one of A1, A2, A3, A4 is At least one

[0016] Among them, A1, A2, A3, and A4 can be the same or different;

[0017] wherein n is 0-100, preferably 1-50, more preferably 1-10;

[0018] R1 and R2 can be the same or different, and they can be any anion, including fluoride ion, chloride ion, bromide ion, iodide ion, hexafluorophosphate particle, acetate ion, etc. Changing the anion does not affect the protection content of the present invention.

[0019] As a preferred technical solution of the present invention, the compound is selected from Compared with other compounds that can be used as fluorescent probes, this compound has a low fluorescence background. After binding to OMV, its fluorescence is enhanced, and the generation of OMV can be sensitively detected.

[0020] As a preferred technical solution of the present invention, the fluorescence in the solution of these compounds is very weak, or no fluorescence is emitted.

[0021] As a preferred technical solution of the present invention, these compounds do not emit light or emit weak light in buffer or MOPS culture medium.

[0022] As a preferred technical solution of the present invention, when these compounds are used to stain Gram-negative bacteria in a buffer solution or MOPS culture medium, the Gram-negative bacteria do not emit light or emit very weak light.

[0023] As a preferred technical solution of the present invention, when Gram-negative bacteria produce OMVs under stimulation conditions, including chemical stimulation, temperature stimulation, physical stimulation, etc., incubation with these compounds can enhance the fluorescence of the solution.

[0024] As a preferred technical solution of the present invention, the chemical substance stimulation includes antibiotic stimulation, including but not limited to ampicillin, kanamycin, aztreonam, and chloramphenicol.

[0025] As a preferred technical solution of the present invention, when these compounds are bound to OMV, their fluorescence will be enhanced.

[0026] As a preferred technical solution of the present invention, Gram-negative bacteria that secrete OMVs will also be bound by these compounds, and the fluorescence will be enhanced.

[0027] As a preferred technical solution of the present invention, the concentration of these compounds is in the range of 0.01 micromolar to 10 millimolar, preferably 0.1 micromolar to 1 millimolar, and more preferably 1 micromolar to 500 micromolar.

[0028] As a preferred technical solution of the present invention, there is no limitation on the types of Gram-negative bacteria that produce OMVs.

[0029] As a preferred technical solution of the present invention, the Gram-negative bacteria are selected from EcN (E. coli Nissle 1917).

[0030] As a preferred technical solution of the present invention, OMVs are produced by bacteria, and the bacteria can be Gram-positive bacteria or Gram-negative bacteria.

[0031] The beneficial effects of the present invention compared to the prior art include:

[0032] The present invention uses a new type of fluorescent material to detect the presence of OMVs. This type of material does not emit fluorescence or emits weak fluorescence in a buffer solution or in a MOPS culture medium. In the presence of Gram-negative bacteria, it emits very weak fluorescence or no fluorescence. When it is bound to OMVs, the fluorescence is enhanced. Therefore, the production of OMVs can be detected based on the change in its fluorescence intensity, and various factors that can induce the production of OMVs can be screened in high throughput, including antibiotic treatments of different types / concentrations. It is conducive to quickly identifying the production of OMVs and determining the optimal conditions for inducing the production of OMVs. It is of great significance for studying OMVs. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] Figure 1 .Changes in fluorescence intensity of OTM under different conditions, OD 600 represents the concentration of EcN (E.coli Nissle 1917), where:

[0034] 1. Fluorescence photos of EcN cultured for 5 hours in the presence of 10 μmol / L OTM;

[0035] 2. Fluorescence photos of EcN cultured for 5 hours under 1 μg / mL ampicillin and in the presence of 10 μmol / L OTM;

[0036] 3. After EcN was cultured for 5 hours under the condition of 1 μg / mL ampicillin, the supernatant was removed and the bacterial part was redispersed, and the fluorescence photo in the presence of 10 μmol / L of the compound was taken;

[0037] 4. Fluorescence photograph of the supernatant in the presence of 10 μmol / L of the compound after EcN was cultured for 5 hours under the condition of 1 μg / mL ampicillin;

[0038] 5. Fluorescence photos of ampicillin alone and in the presence of 10 μmol / L of the compound. The experiment showed that ampicillin induced the production of OMVs, which were in the supernatant and emitted fluorescence.

[0039] Figure 2 .The relative fluorescence intensity of EcN in the presence of 10μmol / L OTM after culturing for 5 hours under different concentrations of antibiotics. I0 is the fluorescence intensity of EcN in the absence of antibiotics and after adding 10μmol / L OTM for 5 hours; I is the fluorescence intensity of EcN in the presence of different concentrations of antibiotics and after adding 10μmol / L OTM for 5 hours. d This is the fluorescence intensity of 10 μmol / L OTM when only MOPS medium was used. DETAILED DESCRIPTION

[0040] The present invention will be further described below in conjunction with embodiments and drawings, but the present invention is not limited thereto.

[0041] Example 1

[0042]

[0043] The molecular structure of the compound used.

[0044] OTM Characterization Data

[0045] 1 H NMR (CD3OD, 400MHz): δ (TMS, ppm) 8.85 (d, 1H, J=6Hz, Ar), 8.24 (d, 1H, J=6Hz, Ar), 8.03-7.99 (m, 1H, CH=C), 7.82-7.79 (m, 2H, Ar), 7.82-7.68 (m, 2H, Ar), 7.50-7.43 (m, 3H, Ar), 7.13-6.89 (m, 14H, Ar), 6 .72-6.66 (m, 2H, Ar), 4.63 (t, 2H, J=8Hz, alkyl), 4.05-4.03 (m, 2H, alkyl), 3.80-3.77 (m, 2H, alkyl ), 3.68-3.49 (m, 11H, alkyl), 3.20 (s, 9H, alkyl), 2.60-2.52 (m, 2H, alkyl), 1.89ppm (s, 6H, alkyl); 13 C NMR (125MHz, CD3OD): δ (TMS, ppm) 180.05 (RCOO), 159.18, 159.08, 156.23, 145.57, 145.44, 145.36, 145.30, 145.24, 14 4.40, 143.34, 142.65, 141.05, 138.91, 137.58, 135.37, 133.69, 133.65, 133.20, 132.51, 132.46, 130.18, 128.95, 128. 90, 128.85, 128.76, 128.45, 127.75, 127.59, 127.27, 127.19, 125.49, 123.59, 115.03, 114.88(Ar), 72.99, 72.97, 71. 76, 71.59, 71.42, 71.40, 70.85, 68.53, 63.91, 59.13, 58.14, 53.94, 26.00, 24.24 (alkyl).HRMS (ESI-Q-TOF, m / z)calcd for(C 52 H 58 N2O42+ )[(M-2(CH3COO)) 2+ ]387.2193, found 387.2167.

[0046] Example 2

[0047] Fluorescence when compound OTM of Example 1 was added to different cultures containing EcN (E. coli Nissle 1917):

[0048] Specific results refer to Figure 1 .Changes in fluorescence intensity of OTM under different conditions, OD 600 Represents the concentration of EcN (E.coliNissle 1917).

[0049] 1. Fluorescence photos of EcN (37°C MOPS medium) in the presence of 10 μmol / L OTM after 5 hours of culture;

[0050] 2. Fluorescence photos of EcN cultured for 5 hours under 1 μg / mL ampicillin and in the presence of 10 μmol / L OTM;

[0051] 3. After EcN was cultured for 5 hours under the condition of 1 μg / mL ampicillin, the supernatant was removed and the bacterial part was redispersed, and the fluorescence photo in the presence of 10 μmol / L of the compound was taken;

[0052] 4. Fluorescence photograph of the supernatant in the presence of 10 μmol / L of the compound after EcN was cultured for 5 hours under the condition of 1 μg / mL ampicillin;

[0053] 5. Fluorescence photographs of ampicillin alone in the presence of 10 μmol / L of the compound.

[0054] The experiment showed that ampicillin induced the production of OMVs, and the OMVs were in the supernatant, which emitted fluorescence.

[0055] Figure 1 Among them, 2 contains both supernatant and bacteria, so the fluorescence is the strongest. 3 contains bacteria, and after the production of OMVs, the bacterial structure changes and the fluorescence is enhanced. 4. The OMVs in the supernatant bind to the probe, resulting in a significantly enhanced fluorescence than 5.

[0056] Example 2

[0057] The fluorescence of the compound OTM of Example 1 when added to the medium containing EcN (E.coli Nissle 1917) with different concentrations of antibiotics:

[0058] Specific results refer to Figure 2Relative fluorescence intensity of EcN (37°C MOPS medium) in the presence of 10 μmol / L OTM after 5 h of culture under different antibiotic concentrations.

[0059] Where, I0 is the fluorescence intensity of 10 μmol / L OTM added after EcN was cultured for five hours without antibiotics; I is the fluorescence intensity of 10 μmol / L OTM added after EcN was cultured for five hours in the presence of different concentrations of antibiotics; I d This is the fluorescence intensity of 10 μmol / L OTM when only MOPS medium was used.

[0060] like Figure 2 As shown, the concentration range of ampicillin in the range of 0.25-5 μg / mL can induce the production of OMVs more efficiently than kanamycin, indicating that the fluorescent probe of the present invention can quickly identify the situation of antibiotic induction.

[0061] The above contents are further detailed descriptions of the present invention in combination with specific preferred embodiments, and it cannot be determined that the specific implementation of the present invention is limited to these descriptions. For ordinary technicians in the technical field to which the present invention belongs, several simple deductions or substitutions can be made without departing from the concept of the present invention, which should be regarded as falling within the protection scope of the present invention.

Claims

1. Application of a fluorescent probe in outer membrane vesicle (OMV) detection, characterized in that: The compound is: This app does not contain disease treatment or diagnosis methods.

2. The use of the fluorescent probe according to claim 1 in outer membrane vesicle (OMV) detection, characterized in that: When the compound is used to stain Gram-negative bacteria in a buffer or MOPS culture medium, the Gram-negative bacteria do not emit light. When OMVs are produced under chemical stimulation, temperature stimulation, or physical stimulation, incubation with the compound enhances the fluorescence of the solution.

3. The use according to claim 2, characterized in that: When the compound binds to OMVs, their fluorescence is enhanced.

4. The use according to claim 2, characterized in that: Gram-negative bacteria that secrete OMVs are also bound by these compounds, resulting in enhanced fluorescence.

5. The use according to claim 2, characterized in that: The compounds were used at concentrations ranging from 0.01 μmol / L to 10 mmol / L.

6. The use according to claim 2, characterized in that: The compounds were used at concentrations ranging from 0.1 μmol / L to 1 mmol / L.

7. The use according to claim 2, characterized in that: The compounds were used at concentrations ranging from 1 μmol / L to 500 μmol / L.